BNP/CALL/BRISTOL-MYERS SQUIBB/75/0.1/17.01.25 Stock BNP/CALL/BRISTOL-MYERS SQUIBB/75/0.1/17.01.25
Add to a list
To use this feature you must be a member
Log inSign up

BNP/CALL/BRISTOL-MYERS SQUIBB/75/0.1/17.01.25 Share Price

Warrant

DE000PE896E1

Delayed Deutsche Boerse AG 04:20:37 28/06/2024 pm IST
0.003 EUR 0.00% Intraday chart for BNP/CALL/BRISTOL-MYERS SQUIBB/75/0.1/17.01.25
Current month+50.00%
1 month+200.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart BRISTOL-MYERS SQUIBB COMPANY
Chart BNP/CALL/BRISTOL-MYERS SQUIBB/75/0.1/17.01.25

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Purple Biotech Says Interim Data from Pancreatic Cancer Drug Study Shows Promise MT
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours MT
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment MT
Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees MT
More news

Quotes 5-day view

Date Price Change
28/24/28 0.003 0.00%
27/24/27 0.003 -25.00%
26/24/26 0.004 +33.33%
25/24/25 0.003 -25.00%
24/24/24 0.004 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 04:20 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BRISTOL-MYERS SQUIBB COMPANY
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE896E
ISINDE000PE896E1
Date issued 16/02/2023
Strike 75 $
Maturity 17/01/2025 (204 Days)
Parity 10 : 1
Emission price 0.76 €
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.81 €
Lowest since issue 0.001 €
Spread 0.088 €
Spread %96.70%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.
Sector
-
More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Bristol-Myers Squibb Company

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.51 USD
Average target price
53.19 USD
Spread / Average Target
+28.15%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant